NEW NAME—Baxalta in Newbury Park manufactures pharmaceuticals, primarily products used to treat hemophilia and other blood diseases.
Baxter International, a Fortune 500 company with a long history in Thousand Oaks, received an overhaul this summer, splitting into two separate entities, each handling different aspects of the healthcare industry.
The change affected the two Baxter locations in the city. They are now part of the spinoff, Baxalta, which focuses on pharmaceuticals, mainly medic...
Oops! An active online subscription is required to access this content.
Please login below or Subscribe today!